Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
37M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
34.1M
-
Shares change
-
+921K
-
Total reported value, excl. options
-
$1.8B
-
Value change
-
+$52.4M
-
Put/Call ratio
-
0.05
-
Number of buys
-
94
-
Number of sells
-
-66
-
Price
-
$52.96
Significant Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q2 2025
185 filings reported holding IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.1M shares
of 37M outstanding shares and own 92.17% of the company stock.
Largest 10 shareholders include FMR LLC (3.25M shares), Atlas Venture Life Science Advisors, LLC (2.38M shares), BlackRock, Inc. (2.04M shares), Frazier Life Sciences Management, L.P. (1.65M shares), RA CAPITAL MANAGEMENT, L.P. (1.58M shares), JANUS HENDERSON GROUP PLC (1.55M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.52M shares), WELLINGTON MANAGEMENT GROUP LLP (1.43M shares), ORBIMED ADVISORS LLC (1.42M shares), and VANGUARD GROUP INC (1.4M shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.